维普中文期刊产品整合服务
223篇 您的检索式:作者名="LINCOFF AM"
    题名 作者 年代 出处 被引量
1Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus:a meta-analysis of randomized trials显示文摘Lincoff AM Wolski K Nicholls SJ 2007JAMA2007,298,:1
2Bivalirudin and prov-isional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/Illa blockade during percutaneous coronary intervention:REPLACE-2 randomized trial显示文摘Lincoff AM Bittl JA Harrington RA 2003JAMA2003,28,13:1
3Characteristics and consequences of myocardial infarction after percutaneous coronary intervention:insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)显示文摘Harrington RA Lincoff AM Califf RM 1995J Am Coll Cardiol1995,25,7:1
4Cell adhesion molecules in coronary artery disease 显示文摘Jang Y Lincoff AM Plow EF 1994J Am Coll Cardiol1994,24,:1
5Magnitude and consequences of missing the acute infarct-related circumflex artery显示文摘Krishnaswamy A Lincoff AM Menon V 0,,:1
6Intravenous platelet blockade with cangrelor during PCI显示文摘Bhatt DL Lincoff AM Gibson CM 2009N Engl J Med2009,361,24:1
7Should glycoprotein Ⅱ b/ Ⅲ a inhibitors be used during all percutaneous coronary intervention? YES显示文摘Exaire JE Lincoff AM 2004J Thromb Haemost2004,2,1:1
8接受最佳治疗的高危血管病患者中C反应蛋白对脂蛋白(a)相关心血管病风险的影响显示文摘脂蛋白(a)是动脉粥样硬化性心血管病的遗传致病危险因素,但目前还不清楚哪些动脉粥样硬化性心血管病患者从脂蛋白(a)降低中受益最大。在二级预防中炎症是否会调节与脂蛋白(a)相关的心血管病风险也未知。该文旨在确定在接受最佳治疗的高危心血管病患者中,脂蛋白(a)相关的心血管病风险是否受到全身炎症的调节。周卫(译) 刘莉(摘/审校) Puri R Nissen SE Arsenault BJ St John J Riesmeyer JS Ruotolo G McErlean E Menon V Cho L Wolski K Lincoff AM Nicholls SJ 2020中华高血压杂志2020,28,11:1
9Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition in complex atherosclerotic lesions显示文摘Cura FA Bhatt DL Lincoff AM 2000Circulation2000,102,:1
10Bivalirudin and pro- visional glycoprotein II b/Ill a blockade compared with heparin and planned glycoprotein II b/m a blockade during percutaneous coronary intervention: REPLACE-2 randomized trial显示文摘Lincoff AM Bittl JA Harrington RA 2003JAMA2003,289,7:1
11Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile 显示文摘Lincoff AM Popma JJ Ellis SG 1992J Am Coil Cardiol1992,19,:1
12Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model 显示文摘Lincoff AM Furst JG Ellis SG 1997J Am Coil Cardiol1997,29,:1
13Magnitude and conse-quences of missing the acute infarct-related circumflex artery 显示文摘Krishnaswamy A Lincoff AM Menon V 2009Am Heart J2009,158,5:1
14Influence of local delivery of the protein kinase receptor inhibitor tyrphostin-47 on smooth muscle cell proliferation in a rat carotid balloon-injury model显示文摘Gottsauner WM Jang Y Lincoff AM 1997Am Heart J1997,133,3:1
15Outcome at 1 year and economic implications of platelet glycoprotein Ⅱb/Ⅲa blockade in patients undergoing coronary stenting:results from a multicentre randomised trial显示文摘Topol EJ Mark DB Lincoff AM 1999EPISTENT Investigators1999,354,9195:1
16Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials显示文摘Lincoff AM Wolski K Nicholls SJ 2007JAMA2007,298,10:1
17Relationship between activated clotting time and ischemic or hemorrhagic complications:analysis of 4 recent randomized clinical trials of percutaneous coronary intervention显示文摘 Moliterno DJ Lincoff AM 2004Circulation2004,10,8:1
18Platelet glycoprotein Ⅱb/Ⅲa receptor blockade in coronary artery disease 显示文摘Lincoff AM Califf RM Topol El 2000JACC2000,35,:1
19Intravenous plateletblockade with cangrelor during PCI显示文摘Bhatt DL Lincoff AM Gibson CM 2009N Engl J Med2009,361,24:1
20Bivalirudin with planned or provisional abciximab versus low dose heparin and abeiximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)显示文摘Lincoff AM Kleiman NS Kottke-Marchant K 2002Am Heart J2002,143,5:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费